Volume Replacement
Editat de Jean-Francois Baron, Johannes Treiben Limba Engleză Paperback – 10 mai 1998
Preț: 353.82 lei
Preț vechi: 372.44 lei
-5% Nou
Puncte Express: 531
Preț estimativ în valută:
67.71€ • 70.34$ • 56.25£
67.71€ • 70.34$ • 56.25£
Carte tipărită la comandă
Livrare economică 04-18 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783540641872
ISBN-10: 3540641874
Pagini: 156
Ilustrații: X, 143 p. 23 illus.
Dimensiuni: 155 x 235 x 8 mm
Greutate: 0.23 kg
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3540641874
Pagini: 156
Ilustrații: X, 143 p. 23 illus.
Dimensiuni: 155 x 235 x 8 mm
Greutate: 0.23 kg
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchDescriere
Because of their therapeutic safety, hydroxyethylstarch, gelatin and dextrans are among the most frequently used drugs in the world. Recent studies have shown that bleeding disorders, anaphylactic reactions and storage in the body depend decisively on the nature of the administered plasma substitute. Through interdisciplinary cooperation the "First European Volume Replacement Conference" has established indications for the use of individual plasma substitutes to improve the efficacy and therapeutic safety of volume replacement therapy.
Cuprins
1 Albumin: To Use or Not to Use? Contemporary Alternatives?.- 2 Use of Gelatines as Volume Expanders in Shock and Trauma.- 3 Which Hydroxyethyl Starch for Which Indication?.- 4 Volume Replacement Therapy with Dextrans: Dextrans Still Useful in Volume Replacement?.- 5 Volume Replacement in the Critically Ill.- 6 Bleeding Complications and Hydroxyethyl Starch: Strategies of Prevention.- 7 Volume Replacement in Burn Patients.- 8 Use of Plasma Substitutes During Cardiac Surgery: Focus on Priming Solutions.- 9 Adverse Renal Effects of Colloidal Solutions.- 10 New Therapeutic Concepts Using Oxygen Carriers.
Textul de pe ultima copertă
Because of their therapeutic safety, hydroxyethylstarch, gelatin and dextrans are among the most frequently used drugs in the world. Recent studies have shown that bleeding disorders, anaphylactic reactions and storage in the body depend decisively on the nature of the administered plasma substitute. Through interdisciplinary cooperation the "First European Volume Replacement Conference" has established indications for the use of individual plasma substitutes to improve the efficacy and therapeutic safety of volume replacement therapy.